Biomaterial Database

Oral contraceptive use and breast cancer in young women in Sweden. 1985

H Olsson, and M L Olsson, and T R Möller, and J Ranstam, and P Holm

UI	MeSH Term	Description	Entries
D008875	Middle Aged	An adult aged 45 - 64 years.	Middle Age
D001943	Breast Neoplasms	Tumors or cancer of the human BREAST.	Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D003276	Contraceptives, Oral	Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both.	Low-Dose Oral Contraceptive,Oral Contraceptive,Oral Contraceptives,Oral Contraceptives, Low-Dose,Oral Contraceptives, Phasic,Contraceptive, Low-Dose Oral,Contraceptive, Oral,Contraceptives, Low-Dose Oral,Contraceptives, Phasic Oral,Low Dose Oral Contraceptive,Low-Dose Oral Contraceptives,Oral Contraceptive, Low-Dose,Oral Contraceptives, Low Dose,Phasic Oral Contraceptives
D005260	Female		Females
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328	Adult	A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.	Adults
D013548	Sweden	Country in northern Europe, bordering the Baltic Sea, between Finland and Norway. The capital is Stockholm.

Related Publications

H Olsson, and M L Olsson, and T R Möller, and J Ranstam, and P Holm

Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and Norway.

September 1986, Lancet (London, England),

H Olsson, and M L Olsson, and T R Möller, and J Ranstam, and P Holm

Oral contraceptive use and the risk of breast cancer in young women.

June 1984, MMWR. Morbidity and mortality weekly report,

H Olsson, and M L Olsson, and T R Möller, and J Ranstam, and P Holm

Oral contraceptive use and breast cancer: a prospective study of young women.

October 2010, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,

H Olsson, and M L Olsson, and T R Möller, and J Ranstam, and P Holm

Breast cancer among young U.S. women in relation to oral contraceptive use.

April 1994, Journal of the National Cancer Institute,

H Olsson, and M L Olsson, and T R Möller, and J Ranstam, and P Holm

Oral contraceptive use and cyclin D1 overexpression in breast cancer among young women.

October 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,

H Olsson, and M L Olsson, and T R Möller, and J Ranstam, and P Holm

The association between oral contraceptive use and lobular and ductal breast cancer in young women.

February 2008, International journal of cancer,

H Olsson, and M L Olsson, and T R Möller, and J Ranstam, and P Holm

Breast cancer and oral contraceptive use in Asian-American women.

September 1999, American journal of epidemiology,

H Olsson, and M L Olsson, and T R Möller, and J Ranstam, and P Holm

Oral contraceptive use and early abortion as risk factors for breast cancer in young women.

January 1981, British journal of cancer,

H Olsson, and M L Olsson, and T R Möller, and J Ranstam, and P Holm

Oral contraceptive use in women with spina bifida in Sweden.

April 2024, Disability and health journal,